IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome

Clinical trial NCT06451198 · RECRUITING

Trial details

NCT number: NCT06451198
Sponsor: Shanghai Zhongshan Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease Antiplatelet Drugs

Start date: 2025-05-19
Primary completion: 2028-12-31
Enrollment: 2846

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.